A review of radiation countermeasures focusing on injury-specific medicinals and regulatory approval status: part III. Countermeasures under early stages of development along with ‘standard of care’ medicinal and procedures not requiring regulatory approval for use-Reference-Cited by-同舟云学术

A review of radiation countermeasures focusing on injury-specific medicinals and regulatory approval status: part III. Countermeasures under early stages of development along with ‘standard of care’ medicinal and procedures not requiring regulatory approval for use

Published:2017-06-28 Issue:9 Volume:93 Page:885-906
ISSN:0955-3002
Container-title:International Journal of Radiation Biology
language:en
Short-container-title:International Journal of Radiation Biology

Author:

Singh Vijay K.¹²,Hanlon Briana K.¹²,Santiago Paola T.¹²,Seed Thomas M.³

Affiliation:

1. Division of Radioprotection, Department of Pharmacology and Molecular Therapeutics, F. Edward Hébert School of Medicine, Uniformed Services University of the Health Sciences, Bethesda, MD, U.S.A.;

2. Armed Forces Radiobiology Research Institute, Uniformed Services University of the Health Sciences, Bethesda, MD, U.S.A.;

3. Tech Micro Services, Bethesda, MD, U.S.A.

Publisher

Informa UK Limited

Subject

Radiology Nuclear Medicine and imaging,Radiological and Ultrasound Technology

Link

https://www.tandfonline.com/doi/pdf/10.1080/09553002.2017.1332440

Reference220 articles.

1. Intravenous administration of mesenchymal stem cells genetically modified with extracellular superoxide dismutase improves survival in irradiated mice

2. Molecular Targets and Anticancer Potential of Indole-3-Carbinol and Its Derivatives

3. Single-Dose Prevention or Short-Term Treatment with Fibroblast Growth Factor-20 (CG53135-05) Reduces the Severity and Duration of Oral Mucositis

4. Amgen Inc. 2015a. Neulasta (pegfilgrastim) injection for subcutaneous use [Internet]. Available from: http://pi.amgen.com/united_states/neulasta/neulasta_pi_hcp_english.pdf

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Enhanced thorium decorporation and mitigation of toxicity through combined use of Liv52® and diethylenetriamine pentaacetate;Journal of Hazardous Materials;2024-09

2. О новом подходе к изучению и оценке эффективности ДНК-специфичных радиопротекторов;Химия высоких энергий;2024-08-29

3. New pharmaceutical-based strategies that foster the development and promulgation of globally effective medical countermeasures for radiation exposure injuries;Expert Opinion on Pharmacotherapy;2024-08-12

4. An Overview of Radiation Countermeasure Development in Radiation Research from 1954 to 2024;Radiation Research;2024-07-05

5. Cell Therapies for Acute Radiation Syndrome;International Journal of Molecular Sciences;2024-06-26